Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment

Fig. 4

Drivers of active 1L vs BSC in patients with GC/GEJC/EAC, HER2 negative/unknown, on first-line treatment. 1L, first-line; BSC, best supportive care; BMI, Body Mass Index; CCI, Charlson Comorbidity Index; EAC, esophageal adenocarcinoma; ECOG, Eastern Cooperative Oncology Group; GC, gastric cancer; GEJC, gastroesophageal junction cancer. * p < 0.05, † base category. Regular heavy drinker and binge drinker omitted due to perfect prediction of no active 1L treatment

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us